Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators..

N Engl J Med. 2004 May 20;350(21):2151-8.

2.

The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.

Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.

Europace. 2004 Sep;6(5):400-6. Erratum in: Europace. 2005 Jan;7(1):91.

PMID:
15294264
3.

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators..

N Engl J Med. 2004 Dec 9;351(24):2481-8.

4.

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators..

N Engl J Med. 2002 Mar 21;346(12):877-83. Epub 2002 Mar 19.

5.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.

7.

Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.

Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):696-704. doi: 10.1111/j.1540-8159.2009.02669.x. Epub 2010 Jan 5.

PMID:
20059719
8.

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).

Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH.

Circulation. 2002 Mar 26;105(12):1453-8.

10.

Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.

Schaer BA, Ammann P, Sticherling C, Zellweger MJ, Cron TA, Osswald S.

Int J Cardiol. 2006 Mar 22;108(1):26-30.

PMID:
16516695
11.

Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.

Grimm W, Christ M, Bach J, Müller HH, Maisch B.

Circulation. 2003 Dec 9;108(23):2883-91. Epub 2003 Nov 17.

12.

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators..

N Engl J Med. 2004 May 20;350(21):2140-50.

13.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators..

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. Epub 2007 Oct 22.

14.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators..

N Engl J Med. 2005 Jan 20;352(3):225-37. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

15.
16.

Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.

Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C.

Int Heart J. 2006 Sep;47(5):763-73.

17.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
18.

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".

Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.

Am J Cardiol. 2012 Mar 1;109(5):729-35. doi: 10.1016/j.amjcard.2011.10.033. Epub 2011 Dec 15.

PMID:
22176998
19.

Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.

Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA.

J Am Coll Cardiol. 1999 Jun;33(7):1964-70.

20.

Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.

Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, Kadish A.

Arch Intern Med. 2007 Nov 12;167(20):2226-32.

PMID:
17998496

Supplemental Content

Support Center